<DOC>
	<DOC>NCT00915538</DOC>
	<brief_summary>This study will compare the amount of bronchial tube relaxation from the formoterol medicine contained in the symbicort pMeterd Dose Inhaler( a combination of budesonide ,a steroid, and formoterol, a drug which relaxes the bronchial smooth muscle. The comparison will be using the pMDI in the usual fashion to the pMDIs and a spacer which allows more time for breathing in the medication. Breathing tests will be measured over a 12 hour period for the comparison.</brief_summary>
	<brief_title>Comparing Bronchodilation of Symbicort With and With Out Valved Holding Chamber (Aerochamber Plus)</brief_title>
	<detailed_description />
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Asthma with 15% or more increase in FEV1 after 180260 mcg of albuterol pMDI Any illness or condition which might place subject at risk in the study;e.g. some cardiovascular disorders Inability to understand and sign informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Formoterol</keyword>
	<keyword>LABA</keyword>
	<keyword>Symbicort</keyword>
	<keyword>Aerochamber</keyword>
</DOC>